Advertisement
Advertisement

TheBodyPRO.com covers EACS 2013

Building a Better HIV Drug: Nano-Formulated Medicines

December 18, 2013

 7/7 

What the Patients Want

What the Patients Want

According to a recent survey, more than 73% of patients indicated they would definitely or probably try injectable antiretroviral therapy. In terms of dose frequency, 61% were interested in weekly, 72% every two weeks and 84% monthly.

Therefore, there is overwhelming support from the patients themselves, particularly if nano-formulations can improve adherence, lower pill burden and cost, and ultimately improve quality of life.






This article was provided by TheBodyPRO.com. It is a part of the publication The 14th European AIDS Conference (EACS 2013).
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement
Advertisement